Effects of Cytochrome P450 3A4 Inhibitors—Ketoconazole and Erythromycin—on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions-Reference-Cited by-同舟云学术

Effects of Cytochrome P450 3A4 Inhibitors—Ketoconazole and Erythromycin—on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions

Published:2015-09-04 Issue:2 Volume:55 Page:237-247
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Boetsch Christophe,Parrott Neil,Fowler Stephen,Poirier Agnes,Hainzl Dominik,Banken Ludger,Martin-Facklam Meret,Hofmann Carsten

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-015-0312-0.pdf

Reference28 articles.

1. Loftis JM, Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther. 2003;97(1):55–85.

2. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry. 2001;158(9):1367–77.

3. Alberati D, Moreau JL, Lengyel J, Hauser N, Mory R, Borroni E, et al. Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia. Neuropharmacology. 2012;62(2):1152–61. doi: 10.1016/j.neuropharm.2011.11.008 .

4. Umbricht D, Alberati D, Martin-Facklam M, Borroni E, Youssef EA, Ostland M, et al. Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study. JAMA Psychiatry. 2014;71(6):637–46. doi: 10.1001/jamapsychiatry.2014.163 .

5. Committee for Medicinal Products for Human Use. Guideline in the investigation of drug interactions. London: European Medicines Agency; 2012.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of cytochrome P450 3A4 on tissue distribution of humantenmine, koumine, and gelsemine, three alkaloids from the toxic plant Gelsemium;Toxicology Letters;2024-06

2. Pharmacokinetic profile of bitopertin, a selective GlyT1 inhibitor, in the rat;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-01-12

3. Plasma Therapeutic Drug Monitoring and Clinical Toxicology;Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology;2022

4. Computational Approaches in Preclinical Studies on Drug Discovery and Development;Frontiers in Chemistry;2020-09-11

5. Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies;Current Medicinal Chemistry;2019-10-16